Hematologic response in type i Gaucher's disease after enzyme replacement therapy
Parco, S.; Bruno, G.; Durighello, M.; Giorgini, R.; Simeone, R.; Bembi, B.
Haematologica 84(4): 376-377
1999
ISSN/ISBN: 0390-6078 PMID: 10190956 Document Number: 499853
Document emailed within 1 workday
Related Documents
Cornu, F. 1998: Gaucher's disease and enzyme replacement therapy Annales Pharmaceutiques Francaises 56(3): 102-107Zimran, A.; Elstein, D. 2014: Management of Gaucher disease: enzyme replacement therapy Pediatric Endocrinology Reviews: Per 12(Suppl 1): 82-87
Rosenthal, D.I.; Doppelt, S.H.; Mankin, H.J.; Dambrosia, J.M.; Xavier, R.J.; McKusick, K.A.; Rosen, B.R.; Baker, J.; Niklason, L.T.; Hill, S.C. 1995: Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase Pediatrics 96(4 Pt 1): 629-637
Pérez-Calvo, J.; Giraldo, P.; Pastores, G.M.; Fernández-Galán, M.; Martín-Nuñez, G.; Pocoví, M. 2003: Extended interval between enzyme therapy infusions for adult patients with Gaucher's disease type 1 Journal of Postgraduate Medicine 49(2): 127-131
Pérez-Calvo, J.I.; Giraldo, P.; Giralt, M. 1997: Alglucerase treatment of type i Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease Sangre 42(3): 189-194
Niederau, C.; vom Dahl, S.; Häussinger, D. 1998: First long-term results of imiglucerase therapy of type 1 Gaucher disease European Journal of Medical Research 3(1-2): 25-30
Schiffmann, R. 2006: Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy Acta Neurologica Belgica 106(2): 61-65
Ley-Martos, M.; Salado-Reyes, Mía.J.; Espinosa-Rosso, Rúl.; Solera-García, Jús.; Jiménez-Jiménez, L. 2015: Variability in the clinical presentation of Pompe disease: development following enzyme replacement therapy Revista de Neurologia 61(9): 416-420
Svennerholm, L.; Dreborg, S.; Erikson, A.; Groth, C.G.; Hillborg, P.O.; Håkansson, G.; Nilsson, O.; Tibblin, E. 1982: Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations Progress in Clinical and Biological Research 95: 67-94
Rømer, F.K. 1987: Increase of S-angiotensin-converting enzyme in Gaucher's disease Ugeskrift for Laeger 149(31): 2088-2089
Fukuda, T. 2010: The efficacy of enzyme replacement therapy in pompe disease and secondary pathology in pompe muscle "excessive autophagy" which is relevant to the therapy resistance No to Hattatsu 42(2): 114-116
1996: Gaucher disease. Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease JAMA 275(7): 548-553
Redzić, A.; Begić, F. 2003: Type i Gaucher's disease--a rare genetic metabolic disease Medicinski Arhiv 57(3): 173-176
Devine, E.A.; Beighton, P.; Petersen, E.M.; Desnick, R.J. 1982: Genetic heterogeneity in type i Gaucher disease Progress in Clinical and Biological Research 95: 495-510
Kaminsky, P.; Klein, M.; Jacob, C.; Deibener, J.; Duc, M. 1995: Biclonal gammapathy in type i Gaucher disease Presse Medicale 24(30): 1400
Daniels, L.B.; Robinson, D.B.; Glew, R.H.; Wylin, R.F. 1981: Normal acid-phosphatase and angiotensin converting enzyme activities in serum of a patient with Gaucher's disease Clinical Chemistry 27(10): 1782-1783
Kolodny, E.H.; Ullman, M.D.; Mankin, H.J.; Raghavan, S.S.; Topol, J.; Sullivan, J.L. 1982: Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients Progress in Clinical and Biological Research 95: 33-65
Cano Ruiz, A.; Martín Scapa, A.; Monescillo Francia, A.; Moreno Caparrós, A. 1998: Gaucher's disease type I: an infrequent cause of portal hypertension Anales de Medicina Interna 15(9): 483-484
Boda, A.; Erdós, M.; Tóth, J.; Nagy, J.; Maródi, László. 2003: Rapidly developing bone destruction in a patient with type 1 Gaucher disease Orvosi Hetilap 144(13): 625-627
Schneider, M.U.; Knoll-Ruzicka, M.L.; Domschke, S.; Heptner, G.; Domschke, W. 1985: Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis Hepato-Gastroenterology 32(2): 97-102